When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Ocular Therapeutix is a multi-bagger stock with substantial upsides. Despite over two-fold gains, I believe it can appreciate higher due to pending catalysts.
Dextenza is poised to gain the label expansion for the treatment of allergic conjunctivitis.
In the longer horizon, Ocular's Eylea reformulation is likely to become a mega blockbuster.